全文获取类型
收费全文 | 1642篇 |
免费 | 111篇 |
国内免费 | 5篇 |
专业分类
耳鼻咽喉 | 23篇 |
儿科学 | 38篇 |
妇产科学 | 82篇 |
基础医学 | 204篇 |
口腔科学 | 7篇 |
临床医学 | 259篇 |
内科学 | 234篇 |
皮肤病学 | 19篇 |
神经病学 | 170篇 |
特种医学 | 25篇 |
外科学 | 171篇 |
综合类 | 15篇 |
一般理论 | 2篇 |
预防医学 | 283篇 |
眼科学 | 6篇 |
药学 | 92篇 |
中国医学 | 1篇 |
肿瘤学 | 127篇 |
出版年
2023年 | 14篇 |
2022年 | 28篇 |
2021年 | 64篇 |
2020年 | 28篇 |
2019年 | 47篇 |
2018年 | 58篇 |
2017年 | 47篇 |
2016年 | 45篇 |
2015年 | 50篇 |
2014年 | 73篇 |
2013年 | 89篇 |
2012年 | 160篇 |
2011年 | 140篇 |
2010年 | 76篇 |
2009年 | 52篇 |
2008年 | 84篇 |
2007年 | 117篇 |
2006年 | 87篇 |
2005年 | 110篇 |
2004年 | 85篇 |
2003年 | 86篇 |
2002年 | 71篇 |
2001年 | 14篇 |
2000年 | 6篇 |
1999年 | 14篇 |
1998年 | 14篇 |
1997年 | 7篇 |
1996年 | 9篇 |
1995年 | 12篇 |
1994年 | 10篇 |
1993年 | 11篇 |
1992年 | 7篇 |
1991年 | 2篇 |
1990年 | 4篇 |
1989年 | 2篇 |
1988年 | 4篇 |
1987年 | 2篇 |
1986年 | 3篇 |
1984年 | 3篇 |
1983年 | 5篇 |
1981年 | 3篇 |
1979年 | 2篇 |
1978年 | 1篇 |
1976年 | 1篇 |
1974年 | 1篇 |
1973年 | 3篇 |
1972年 | 1篇 |
1971年 | 1篇 |
1970年 | 1篇 |
1967年 | 1篇 |
排序方式: 共有1758条查询结果,搜索用时 31 毫秒
41.
42.
Susan Yung Sing Leung Lui Chris K.F. Ng Andrew Yim Maggie K.M. Ma Kin Yee Lo Chik Cheung Chow Kwok Hong Chu Wai Leung Chak Man Fai Lam Chun Yu Yung Terence P.S. Yip Sunny Wong Colin S.O. Tang Flora S.K. Ng Tak Mao Chan 《Peritoneal dialysis international》2015,35(2):147-158
♦ Background: The impact of a low-glucose peritoneal dialysis (PD) regimen on biomarkers of peritoneal inflammation, fibrosis and membrane integrity remains to be investigated.♦ Methods: In a randomized, prospective study, 80 incident PD patients received either a low-glucose regimen comprising Physioneal (P), Extraneal (E) and Nutrineal (N) (Baxter Healthcare Corporation, Deerfield, IL, USA) (PEN group), or Dianeal (control group) for 12 months, after which both groups continued with Dianeal dialysis for 6 months. Serum and dialysate levels of vascular endothelial growth factor (VEGF), decorin, hepatocyte growth factor (HGF), interleukin-6 (IL-6), macrophage migration inhibitory factor (MIF), hyaluronan (HA), adiponectin, soluble-intracellular adhesion molecule (s-ICAM), vascular cell adhesion molecule-1 (VCAM-1) and P-selectin, and dialysate cancer antigen 125 (CA125), were measured after 12 and 18 months. This paper focuses on results after 12 months, when patients in the PEN group changed to glucose-based PD fluid (PDF).♦ Results: At the end of 12 months, effluent dialysate levels of CA125, decorin, HGF, IL-6, adiponectin and adhesion molecules were significantly higher in the PEN group compared to controls, but all decreased after patients switched to glucose-based PDF. Macrophage migration inhibitory factor level was lower in the PEN group but increased after changing to glucose-based PDF and was similar to controls at 18 months. Serum adiponectin level was higher in the PEN group at 12 months, but was similar in the 2 groups at 18 months. Body weight, residual renal function, ultrafiltration volume and total Kt/V did not differ between both groups. Dialysate-to-plasma creatinine ratio at 4 h was higher in the PEN group at 12 months and remained so after switching to glucose-based PDF.♦ Conclusion: Changes in the biomarkers suggest that the PEN PD regimen may be associated with better preservation of peritoneal membrane integrity and reduced systemic vascular endothelial injury. 相似文献
43.
Sean Molloy Maggie Lai Guy Pratt Karthik Ramasamy David Wilson Nasir Quraishi Martin Auger David Cumming Maqsood Punekar Michael Quinn Debo Ademonkun Fenella Willis Jane Tighe Gordon Cook Alistair Stirling Timothy Bishop Cathy Williams Bronek Boszczyk Jeremy Reynolds Mel Grainger Niall Craig Alastair Hamilton Isobel Chalmers Sam Ahmedzai Susanne Selvadurai Eric Low Charalampia Kyriakou the UK Spinal Myeloma Working Group 《British journal of haematology》2015,171(3):332-343
Myeloma is one of the most common malignancies that results in osteolytic lesions of the spine. Complications, including pathological fractures of the vertebrae and spinal cord compression, may cause severe pain, deformity and neurological sequelae. They may also have significant consequences for quality of life and prognosis for patients. For patients with known or newly diagnosed myeloma presenting with persistent back or radicular pain/weakness, early diagnosis of spinal myeloma disease is therefore essential to treat and prevent further deterioration. Magnetic resonance imaging is the initial imaging modality of choice for the evaluation of spinal disease. Treatment of the underlying malignancy with systemic chemotherapy together with supportive bisphosphonate treatment reduces further vertebral damage. Additional interventions such as cement augmentation, radiotherapy, or surgery are often necessary to prevent, treat and control spinal complications. However, optimal management is dependent on the individual nature of the spinal involvement and requires careful assessment and appropriate intervention throughout. This article reviews the treatment and management options for spinal myeloma disease and highlights the value of defined pathways to enable the proper management of patients affected by it. 相似文献
44.
Jason A. Bonomo Maggie C.Y. Ng Nicholette D. Palmer Jacob M. Keaton Chris P. Larsen Pamela J. Hicks The TD-GENES Consortium Carl D. Langefeld Barry I. Freedman Donald W. Bowden 《Clinical journal of the American Society of Nephrology》2014,9(8):1434-1440
Background and objectives
Presumed genetic risk for diabetic and nondiabetic end stage renal disease is strong in African Americans.Design, setting, participants, & measurements
Exome sequencing data from African Americans with type 2 diabetic end stage renal disease and nondiabetic, non-nephropathy controls in the T2D-GENES study (Discovery, n=529 patients and n=535 controls) were evaluated, focusing on missense variants in NPHS1. Associated variants were then evaluated in independent type 2 diabetic end stage renal disease (Replication, n=1305 patients and n=760 controls), nondiabetic end stage renal disease (n=1705), and type 2 diabetes-only, non-nephropathy samples (n=503). All participants were recruited from dialysis facilities and internal medicine clinics across the southeastern United States from 1991 to present. Additional NPHS1 missense variants were identified from exome sequencing resources, genotyped, and sequence kernel association testing was then performed.Results
Initial analysis identified rs35238405 (T233A; minor allele frequency=0.0096) as associated with type 2 diabetic end stage renal disease (adjustment for admixture P=0.042; adjustment for admixture+APOL1 P=0.080; odds ratio, 2.89 and 2.36, respectively); with replication in independent type 2 diabetic end stage renal disease samples (P=0.018; odds ratio, 4.30) and nondiabetic end stage renal disease samples (P=0.016; odds ratio, 4.48). In a combined analysis (all patients with end stage renal disease versus all controls), T233A was associated with all-cause end stage renal disease (P=0.0038; odds ratio, 2.82; n=3270 patients and n=1187 controls). A P-value of <0.001 was obtained after adjustment for admixture and APOL1 in sequence kernel association testing. Two additional variants (H800R and Y1174H) were nominally associated with protection from end stage renal disease (P=0.036; odds ratio, 0.44; P=0.0084; odds ratio, 0.040, respectively) in the locus-wide single-variant association tests.Conclusions
Coding variants in NPHS1 are associated with both risk for and protection from common forms of nephropathy in African Americans. 相似文献45.
46.
47.
Maternal diabetes has been demonstrated to adversely affect preimplantation embryo development and pregnancy outcomes. Emerging data suggest that these effects are associated with compromised oocyte quality. However, direct evidence of a pathway by which maternal diabetes exerts its effects on the oocyte is still lacking. Cumulus cells are metabolically coupled to oocytes, and bidirectional communication between them is essential for the development and functions of both compartments. The primary focus of this work was to evaluate the connection between glucose uptake in cumulus cells and oocyte quality in diabetic mice. This experiment has been difficult, because cumulus cells need to be separated from oocytes and labeled with isotope in the process of measuring glucose uptake. Here, we report a method for live imaging glucose transport in single cumulus-oocyte complexes using a fluorescent glucose analog (6-(N-(7-nitrobenz-2-oxa-1,3-diazol- 4-yl)amino)-6-deoxyglucose). By tracking the ATP content and spindle/chromosome status in individual oocytes surrounded by cumulus cells with differing glucose uptake activity, we reveal that compromised oocyte quality in diabetic mice is linked to decreased glucose uptake in cumulus cells. 相似文献
48.
49.
50.